Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,700 public trials 1,041 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

NCT03117335

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Bengbu medical college affiliated hospital Bengbu, Anhui, China
  • The first affiliated hospital, anhui medical university Hefei, Anhui, China
  • The second affiliated hospital, anhui medical university Hefei, Anhui, China
  • Beijing Chest Hospital Beijing, Beijing Municipality, China
View all 37 locations
View Trial Details
Completed

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

NCT00622193

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Osler Medical Melbourne, Florida, United States
  • Augusta Oncology Associates Augusta, Georgia, United States
  • South Georgia Medical Center Valdosta, Georgia, United States
View all 33 locations
View Trial Details
Completed

A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations

NCT01153984

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • County Hospital Alba; Oncology Alba Iulia, Romania
  • Institut of Oncology Al. Trestioreanu Bucharest; Oncology Bucharest, Romania
  • Institute Of Oncology Bucharest; Medical Oncology Bucharest, Romania
  • Spitalul de Boli Cronice Sf. Luca Bucharest, Romania
View Trial Details
Completed

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

NCT01951690

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Colorado Cancer Center, Anschutz Medical Campus Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

NCT00533884

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +43 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • MBCCOP - Meharry Medical College - Nashville Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

NCT01085136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Boehringer Ingelheim Investigational Site Buenos Aires, Argentina
  • Boehringer Ingelheim Investigational Site Kingswood, New South Wales, Australia
  • Boehringer Ingelheim Investigational Site South Brisbane, Queensland, Australia
  • Boehringer Ingelheim Investigational Site Box Hill, Victoria, Australia
View all 97 locations
View Trial Details

Related conditions